SCHEMBL26324903

SCHEMBL26324903

C=Cc1ccccc1N(CCCC)C(C(=O)OC(C)C)C(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 3/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
MEN1 O00255 2/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 1/20 0.32
GLA P06280 1/20 0.32
HIF1A Q16665 1/20 0.32
TP53 P04637 1/20 0.32
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
LMNA P02545 1/20 0.31
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31
TSHR P16473 2/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20565111 0.88 NPSR1 (0.34) NPSR1POLBKMT2ASMN1; SMN2MEN1
SCHEMBL26324888 0.83 ALDH1A1 (0.41) POLBKMT2AMEN1KDM4EALDH1A1
SCHEMBL26324890 0.79 ALDH1A1 (0.39) POLBKMT2ASMN1; SMN2MEN1MAPT
SCHEMBL26327688 0.78 ALDH1A1 (0.36) NPSR1POLBSMN1; SMN2ALDH1A1TP53
SCHEMBL17313474 0.76 KCNH2 (0.32) NPSR1KMT2AMEN1
SCHEMBL26324915 0.74 HDAC3 (0.38) SMN1; SMN2NPC1RAB9ALMNAPPARG
SCHEMBL26324897 0.73 RAB9A (0.34) POLBKMT2AMEN1ALDH1A1TP53
SCHEMBL26324895 0.72 CHRNB2 (0.37) KMT2ASMN1; SMN2MEN1MAPTPPARG
SCHEMBL25440085 0.71 ALDH1A1 (0.43) POLBKMT2AMEN1KDM4EALDH1A1
SCHEMBL26324924 0.69 TSHR (0.41) POLBALDH1A1LMNATSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 NPSR1 1093/4885POLB 776/4885KMT2A 127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.